Skip to main content
. 2024 May 16;9(8):2514–2526. doi: 10.1016/j.ekir.2024.05.007

Figure 7.

Figure 7

The 17q12del and HNF1B variants in hypomagnesemia or extrarenal disorders. (a) Hypomagnesemia (magnesium < 0.6 mmol/l) was more frequent in patients with the 17q12del compared to patients with HNF1B variants. (b) Hyperuricemia (uric acid > 320 μmol/l) was less frequent in patients with the 17q12del compared to patients with HNF1B variants. (c) Hyperglycemia (fasting blood glucose > 1.26 g/l) was not different in the patient groups. (d) Hypomagnesemia was not different between patients with variants in the POUs, POUh, and transactivation domains. (e) Hyperuricemia was less frequent in patients with variants in the POUh than in the POUs and transactivation domains. (f) Hyperglycemia was not different between patients with variants in the POUs, POUh, and transactivation domains.